The Bulletin
The Times


.

ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

  • Written by PR Newswire
ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

MELBOURNE, Australia, July 11, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into the Phase III pivotal study ZIRCON (Zirconium in Renal Cancer Oncology, NCT03849118) of its investigational renal (kidney) cancer imaging agent...

The Bulletin Magazine

How to Choose a Sliding Screen Door for Indoor-Outdoor Living

What the Label on a Pallet Tells a Warehouse Before Anyone Opens It

Executive Recruitment for Education Leadership: What Schools Should Consider

Practical Guide to Roller Shutters for Safer, More Comfortable Homes

Why the Advertised Rate on a Bonus Saver Account Isn't What Most Savers Actually Earn

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

What Is Included in a Professional Roof Repair Service on the Gold Coast?

The Unglamorous Baby Buys That Save Australian Parents the Most Time

Cryptocurrency Trading in 2026_ Why Regulated Education Is the New Standard

hacklink zlibraryzlibraryz-libraryFanatikbetjojobetcasibomcasibomjojobetjustintvtaraftariummeritkinghacklink panelmarsbahisvsf watchesjojobetuk casinos not on gamstopGamStopen güvenilir bahis siteleri hangileri?